Vall d'Hebron Barcelona Hospital Campus begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis
Vall d’Hebron Barcelona Hospital Campus begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis
- Seraph 100 consists of a filter capable of binding and eliminating microorganisms in the blood of patients who have an infection
- The clinical trials that are now underway will study whether this system can reduce the severity of critical patients with COVID-19 and sepsis
- The Vall d’Hebron University Hospital in Barcelona is the first center in Europe to include patients in the COVID-19 clinical trial. The study, sponsored by ExThera Medical, will also have the participation of Hospital Clínico San Carlos de Madrid, together with the company Cardiolink
